Peter Hecht, CEO, Director at Ironwood Pharma, holds 377.46K shares in Cyclerion Therapeutics (Ticker: CYCN), holds 2.23M shares in Ironwood Pharma (Ticker: IRWD).

See the Hottest Stocks Based on Insider Trading >

Peter Hecht
Ironwood Pharma (IRWD)
CEO, Director

Ranked #85,165 out of 98,743 Corporate Insiders

Profitable Transactions

3 out of 6 Profitable Transactions

Average Return

-26.80%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

94.20%

IRWD

5.80%

CYCN

A breakdown of Peter Hecht's holdings

See the Top Stocks by Insiders

Insider Roles

Ironwood Pharma
(IRWD)

CEO, Director

Cyclerion Therapeutics
(CYCN)

Director, Ten Percent Owner

Roles that Peter Hecht holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Ironwood Pharma
(IRWD)

Rating:Informative Sell

Date:Mar 18, 2015 - Mar 18, 2016

Return:+28.40%

The most profitable trade made by Peter Hecht

See the Latest Stocks Traded by Insiders

Peter Hecht's Trading History

IRWD

Ironwood Pharma

Mar 06, 2019

CEO, Director

Uninformative Sell

―

$18.12M

CYCN

Cyclerion Therapeutics

Jan 26, 2024

Director, Ten Percent Owner

Uninformative Buy

―

$1.12M

List of latest transactions for each holding click on a transaction to see Peter Hecht's performance on stock

See All Insider Trading from Today

Peter Hecht insider profile FAQ

What is the percentage of profitable transactions made by Peter Hecht?

The percentage of profitable transactions made by Peter Hecht is 50%.

What is the average return per transaction made by Peter Hecht?

The average return per transaction made by Peter Hecht is -26.80%.

What stocks does Peter Hecht hold?

Peter Hecht holds: IRWD, CYCN stocks.

What was Peter Hecht’s latest transaction?

Peter Hecht latest transaction was an Uninformative Buy of ―.

What was Peter Hecht's most profitable transaction?

Peter Hecht’s most profitable transaction was an Informative Sell of IRWD stock on March 18, 2015. The return on the trade was 28.40%.

What is Peter Hecht's role in Ironwood Pharma?

Peter Hecht's role in Ironwood Pharma is CEO, Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Peter Hecht Insider Profile

Peter Hecht Ironwood Pharma (IRWD)CEO, Director